Literature DB >> 4194190

Proteolytic degradation of exocrine and serum immunoglobulins.

W R Brown, R W Newcomb, K Ishizaka.   

Abstract

The susceptibility of exocrine and serum immunoglobulins and antibodies to proteolytic degradation was assessed. Colostral and duodenal fluid exocrine 11S IgA, monomeric serum IgA, and IgG were digested with trypsin, chymotrypsin, or duodenal fluid. Exocrine IgA was more resistant to digestion than were the serum immunoglobulins. Under conditions of the experiments, most of colostral IgA retained its 11S quaternary structure, including the secretory piece; the portion degraded was reduced almost entirely to peptides. The superior resistance of exocrine IgA was also demonstrated by digestion of serum IgG and nasal exocrine IgA diphtheria antitoxins with trypsin or duodenal fluid. Selective precipitation of trypsin-digested antitoxins with antibodies to heavy chains, light chains, or secretory piece revealed that the differences in susceptibility to digestion were due to differences in lability of the Fc portions of the IgA and IgG antibody molecules. The Fc portions of IgG antibody molecules were degraded or cleaved from the Fab units of the molecules, whereas the Fc-like portions of IgA antibody molecules remained associated with their Fab-like units and the secretory piece. On the other hand, trypsin treatment did not affect the antigen binding ability of the Fab parts of either the exocrine IgA or IgG antibodies. The Fc-like portions of exocrine IgA may be protected from tryptic degradation by the quaternary structure of the 11S molecules, which includes a dimer of 7S IgA subunits and the secretory piece.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4194190      PMCID: PMC322610          DOI: 10.1172/JCI106354

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Reduction and proteolytic degradation of immunoglobulin A from human colostrum.

Authors:  G Cederblad; B G Johansson; L Rymo
Journal:  Acta Chem Scand       Date:  1966

2.  C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody.

Authors:  T Ishizaka; K Ishizaka; T Borsos; H Rapp
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

3.  Bacterial and viral coproantibodies in breast-fed infants.

Authors:  J F Kenny; M I Boesman; R H Michaels
Journal:  Pediatrics       Date:  1967-02       Impact factor: 7.124

4.  Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes.

Authors:  T Ishizaka; K Ishizaka; S Salmon; H Fudenberg
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

5.  On the significance of the heterogeneity in molecular size of human serum gamma A-globulins.

Authors:  J P Vaerman; H H Fudenberg; C Vaerman; W J Mandy
Journal:  Immunochemistry       Date:  1965-09

6.  Human diphtheria antitoxin in immunoglobulin classes IgG and IgA.

Authors:  R W Newcomb; K Ishizaka
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

7.  Demonstration of IgA polioantibody in saliva, duodenal fluid and urine.

Authors:  R Berger; E Ainbender; H L Hodes; H D Zepp; M M Hevizy
Journal:  Nature       Date:  1967-04-22       Impact factor: 49.962

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

9.  The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva.

Authors:  M A South; M D Cooper; F A Wollheim; R Hong; R A Good
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

10.  A subclass of human gamma-A-globulins (gamma-A2) which lacks the disulfied bonds linking heavy and light chains.

Authors:  H M Grey; C A Abel; W J Yount; H G Kunkel
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  39 in total

1.  Measurement of immunoglobulin concentrations in the feces of healthy dogs.

Authors:  I R Peters; E L Calvert; E J Hall; M J Day
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

2.  Appraisal of gut lavage in the study of intestinal humoral immunity.

Authors:  S O'Mahony; J R Barton; S Crichton; A Ferguson
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. I. Normal tissues.

Authors:  R F Lai A Fat; D B McClelland; R van Furth
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

4.  Clinical aspects of protective immunity of the respiratory tract.

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1975-12       Impact factor: 9.139

Review 5.  Immune components of colostrum and milk--a historical perspective.

Authors:  Thomas T Wheeler; Alison J Hodgkinson; Colin G Prosser; Stephen R Davis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-11-09       Impact factor: 2.673

6.  Structural integrity of host defense factors in dental plaque.

Authors:  S D Hsu; M F Cole
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Immunoglobulin E (IgE) and IgE-containing cells in human gastrointestinal fluids and tissues.

Authors:  W R Brown; B K Borthistle; S T Chen
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

8.  Dog immunoglobulins. I. immunochemical characterization of dog serum, parotid saliva, colostrum, milk and small bowel fluid.

Authors:  R J Heddle; D Rowley
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

9.  Clinical, microbiological, and immunological studies in patients with immunoglobulin deficiencies and gastrointestinal disorders.

Authors:  W R Brown; D Butterfield; D Savage; T Tada
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

10.  Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

Authors:  R Weltzin; S A Hsu; E S Mittler; K Georgakopoulos; T P Monath
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.